This retrospective study investigates the roles of the biomarkers interleukin‐6 (IL‐6) and growth differentiation factor‐15 (GDF‐15), in the context of sarcopenia, assessing their impact on oncological and survival outcomes. Here, IL6 is linked to sarcopenia.